MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WESSELS, M. R.
Right arrow Articles by LEFKOWITZ, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WESSELS, M. R.
Right arrow Articles by LEFKOWITZ, R. J.

Molecular Pharmacology, Vol 16, 10-20, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Selective Alteration in High Affinity Agonist Binding: A Mechanism of Beta-Adrenergic Receptor Desensitization

MICHAEL R. WESSELS 1, DEBRA MULLIKIN 1, and ROBERT J. LEFKOWITZ 1

1 Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Beta-adrenergic receptor desensitization of intact frog erythrocytes results in a greater percent fall in agonist ((±)[3H]hydroxybenzylisoproterenol) than in antagonist ((-)[3H]-dihydroalprenolol) binding. We now report the results of detailed studies on the alterations in agonist binding associated with beta-adrenergic receptor desensitization. Competition binding experiments revealed a lower overall affinity of agonist binding after desensitization. The affinity of antagonist ([3H]dihydroalprenolol) binding appeared unchanged after desensitization. Three reagents (N-ethylmaleimide, EDTA, and Gpp(NH)p) that decrease high affinity agonist binding were shown to have less effect on [3H]hydroxybenzylisoproterenol binding after desensitization. Two such agents (N-ethylmaleimide and dicyclohexyl carbodiimide) were also shown to block desensitization of intact cells. Guanine nucleotides failed to restore beta-adrenergic antagonist ([3H]dihydroalprenolol) binding sites after desensitization. Adenylate cyclase catalytic activity was not impaired by desensitization and remained normally responsive to guanine nucleotides. These findings are consistent with a model of beta-adrenergic receptor desensitization in which desensitized receptors arise from receptors in the high affinity state, with chronic occupancy by agonist. The process of desensitization thus appears to result in selective loss or inactivation of these high affinity agonist binding sites.

Submitted on October 16, 1978
Accepted on January 26, 1979




This article has been cited by other articles:


Home page
ScienceHome page
T. Harden, C. Cotton, G. Waldo, J. Lutton, and J. Perkins
Catecholamine-induced alteration in sedimentation behavior of membrane bound beta-adrenergic receptors
Science, October 24, 1980; 210(4468): 441 - 443.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics